Anti-BCMA novel therapies for multiple myeloma

Recent advances in multiple myeloma therapy have increased the depth of response and ultimately survivals; however, the prognosis remains poor. The BCMA antigen is highly expressed in myeloma cells, thus representing a target for novel therapies. Several agents that target BCMA through different mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sammartano, Vincenzo, Franceschini, Marta, Fredducci, Sara, Caroni, Federico, Ciofini, Sara, Pacelli, Paola, Bocchia, Monica, Gozzetti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099603/
https://www.ncbi.nlm.nih.gov/pubmed/37065871
http://dx.doi.org/10.20517/cdr.2022.138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099603/
https://www.ncbi.nlm.nih.gov/pubmed/37065871
http://dx.doi.org/10.20517/cdr.2022.138

Ejemplares similares